Literature DB >> 12562244

Human parainfluenza virus giant cell pneumonia following cord blood transplant associated with pulmonary alveolar proteinosis.

Kelly J Butnor1, Thomas A Sporn.   

Abstract

Giant cell pneumonia secondary to human parainfluenza virus 3 has been reported only rarely in immunocompromised hosts. The few cases documented after bone marrow transplant have resulted in significant morbidity and mortality. To our knowledge, this entity has not been described following umbilical cord blood transplant. Pulmonary alveolar proteinosis, a rare condition that has been reported with increasing frequency in association with immunocompromise and infections, has not been documented in the setting of either umbilical cord blood transplant or human parainfluenza viral infection. We report what we believe is the first documented case of giant cell pneumonia caused by human parainfluenza virus 3 in an umbilical cord blood transplant recipient. To our knowledge, a unique associated feature of this case, a pulmonary alveolar proteinosis-like reaction, has not been reported previously in association with human parainfluenza virus pneumonia.

Entities:  

Mesh:

Year:  2003        PMID: 12562244     DOI: 10.5858/2003-127-235-HPVGCP

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  2 in total

1.  Viral pneumonia and pulmonary alveolar proteinosis: the cause and the effect, case report.

Authors:  Saeed Mishal Albogami; Abdelfattah A Touman
Journal:  AME Case Rep       Date:  2019-10-16

2.  Successful allogeneic bone marrow transplantation for myelodysplastic syndrome complicated by severe pulmonary alveolar proteinosis.

Authors:  Sumie Tabata; Sonoko Shimoji; Kimihiko Murase; Yoko Takiuchi; Daichi Inoue; Takaharu Kimura; Yuya Nagai; Minako Mori; Katsuhiro Togami; Masayuki Kurata; Kiminari Ito; Hisako Hashimoto; Akiko Matushita; Kenichi Nagai; Takayuki Takahashi
Journal:  Int J Hematol       Date:  2009-08-20       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.